Free Trial
OTCMKTS:BAYRY

Bayer Aktiengesellschaft (BAYRY) Stock Price, News & Analysis

Bayer Aktiengesellschaft logo
$5.83 -0.22 (-3.64%)
As of 04/2/2025 03:59 PM Eastern

About Bayer Aktiengesellschaft Stock (OTCMKTS:BAYRY)

Key Stats

Today's Range
$5.78
$5.86
50-Day Range
$5.42
$6.77
52-Week Range
$4.79
$8.58
Volume
577,577 shs
Average Volume
900,477 shs
Market Capitalization
$22.91 billion
P/E Ratio
N/A
Dividend Yield
0.34%
Price Target
N/A
Consensus Rating
Hold

Company Overview

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration with Acuitas Therapeutics, Inc. to strengthen gene editing programs; Peking University in the area of basic pharmaceutical research; the Swiss Tropical and Public Health Institute in the development of the compound emodepside for the treatment of infection with soil-transmitted helminths; bit.bio Ltd. for the discovery and manufacture of regulatory T cells for use in creating therapeutics; Hologic, Inc. in the field of contrastenhanced-mammography solutions to improve diagnostic imaging for the detection of breast cancer; and Twist Bioscience Corporation centering around the research and development of antibody-based pharmaceuticals, as well as with CrossBay Medical Inc. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. The company has collaboration with Thermo Fisher Scientific. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

Remove Ads
Receive BAYRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bayer Aktiengesellschaft and its competitors with MarketBeat's FREE daily newsletter.

BAYRY Stock News Headlines

Trump Allies Confirm Exec Order 14024 Triggers Dollar Collapse
Executive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth, your savings, and your retirement. When the dollar collapses, your savings could disappear overnight. With Trump threatening Russia with more sanctions, Russia is rushing to finalize their BRICS payment system aimed to destroy the U.S dollar.
FMC, Bayer collaborate to bring Isoflex to European markets
See More Headlines

BAYRY Stock Analysis - Frequently Asked Questions

Bayer Aktiengesellschaft's stock was trading at $4.88 on January 1st, 2025. Since then, BAYRY stock has increased by 19.5% and is now trading at $5.83.
View the best growth stocks for 2025 here
.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY) announced its quarterly earnings data on Tuesday, November, 12th. The company reported $0.07 EPS for the quarter, missing analysts' consensus estimates of $0.17 by $0.10. The business earned $10.96 billion during the quarter. Bayer Aktiengesellschaft had a positive trailing twelve-month return on equity of 16.90% and a negative net margin of 2.02%.

The following companies are subsidiaries of Bayer Aktiengesellschaft: Asklepios BioPharmaceutical, Care/of, KaNDy Therapeutics, BlueRock Therapeutics, Monsanto Company, Zoner.ag, Dihon Pharmaceutical, and others.

Shares of BAYRY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
11/12/2024
Today
4/03/2025
Next Earnings (Estimated)
5/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:BAYRY
Employees
99,723
Year Founded
1863

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
4.45
P/E Growth
N/A
Net Income
$-3,183,040,000.00
Pretax Margin
-3.59%

Debt

Sales & Book Value

Annual Sales
$51.55 billion
Cash Flow
$4.55 per share
Price / Cash Flow
1.28
Book Value
$9.11 per share
Price / Book
0.64

Miscellaneous

Outstanding Shares
3,929,696,000
Free Float
N/A
Market Cap
$22.91 billion
Optionable
Not Optionable
Beta
0.93

Social Links

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (OTCMKTS:BAYRY) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners